• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ECLIPSE FILTER SYSTEM - FEMORAL; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ECLIPSE FILTER SYSTEM - FEMORAL; VENA CAVA FILTER Back to Search Results
Catalog Number EC500F
Device Problems Malposition of Device (2616); Patient Device Interaction Problem (4001)
Patient Problem Abdominal Pain (1685)
Event Date 05/11/2017
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history record review could not be performed as the lot number is unknown.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately four years post filter deployment, patient presented with abdominal pain.Subsequently next month, wound debridement and wound vac placement procedure was performed.Approximately two years later, patient again presented with abdominal pain.Approximately three months later, patient was evaluated for shortness of breath.Approximately five months later, computed tomography revealed inferior vena cava filter was positioned infrarenal at the level, there was a slight apex right tilt and all 6 primary centering struts had perforated the inferior vena cava wall with impingement on overlying small bowel, underlying vertebral body and the aorta.Some of the secondary/centering struts had perforated the inferior vena cava as well.Therefore, the investigation is confirmed for perforation of the inferior vena cava (ivc).However, the investigation is inconclusive for filter tilt.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis.At some time post filter deployment, it was alleged that the filter tilted, struts perforated and the patient reportedly experienced abdominal pain.The device has not been removed and there were no reported attempts made to retrieve the filter.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ECLIPSE FILTER SYSTEM - FEMORAL
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key10486852
MDR Text Key205461888
Report Number2020394-2020-05543
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K093659
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 09/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/03/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberEC500F
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received08/07/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CLARITHROMYCIN, FAMOTIDINE, HYDROCODONE; CODEINE, HYDROXYZINE HCL, HYDROXYZINE PAMOATE; DEXLANSOPRAZOIE, ALBUTEROL, HYDROMORPHONE; DIPHENHYDRAMINE, CLINDAMYCIN HCL; GLUCOVANCE, CLONAZEPAM, LEXAPRO; MOXIFLOXACIN, ESCITALOPRAM, GLYBURIDE; NALBUPHINE, SULFAMETHOXAZOLE, TEMAZEPAM; NEXIUM, ATENOLOL, PRAVASTATIN, HYDROCODONE; NICOTINE, LEVALBUTEROL, FUROSEMIDE, MEPERIDINE; NIZATIDINE, ARISTARIL, DICYCLOMINE HCL; OXYCODONE, PENICILLINS, SULFA; PHENERGAN, LEVOTHYROXINE, GLUCOVANCE; PROTONIX, GASX, MIRTAZAPINE, TRAMADOL; TRIMETHOPRIM, IODINATED CONTRAST, MEPERIDINE HCL
Patient Outcome(s) Other;
Patient Age68 YR
-
-